[Modulation by recombinant alpha-2a-interfer on the activity and site of action of 5-fluorouracil on xenografted human colon cancer in nude mice: preliminary report].
Yoshida
K
K
First Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
Fujikawa
T
T
Tanabe
A
A
Sakurai
K
K
D000818:Animals; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011994:Recombinant Proteins
D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D005472:Fluorouracil